![]() |
Volumn 60, Issue 6, 2001, Pages 2385-2391
|
The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients
a
a
a
a
a
a
a
|
Author keywords
Cellular immunity; Dialysis; Hepatitis B; Inflammation; Kidney failure; Monocyte physiology; Polymorphism; Single nucleotide
|
Indexed keywords
HEPATITIS B VACCINE;
INTERLEUKIN 10;
INTERLEUKIN 6;
RECOMBINANT HEPATITIS B VACCINE;
TRIPLE VACCINE;
ALLELE;
ARTICLE;
CHRONIC INFLAMMATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOWN REGULATION;
ENZYME LINKED IMMUNOSORBENT ASSAY;
GENOTYPE;
HEMODIALYSIS;
HEPATITIS B;
HUMAN;
IMMUNE FUNCTION TEST;
IMMUNITY;
IN VITRO STUDY;
LEUKOCYTE;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
POLYMERASE CHAIN REACTION;
PREVALENCE;
PRIORITY JOURNAL;
PROMOTER REGION;
|
EID: 0035176839
PISSN: 00852538
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1523-1755.2001.00062.x Document Type: Article |
Times cited : (73)
|
References (32)
|